<DOC>
	<DOCNO>NCT01896115</DOCNO>
	<brief_summary>The objective study compare different deep brain stimulation ( DBS ) setting use commercially approve Boston Scientific Neuromodulation Vercise system .</brief_summary>
	<brief_title>CUSTOM-DBS : Current Steering Optimize Deep Brain Stimulation</brief_title>
	<detailed_description>The study prospective , multi-center , double-blind , randomize control trial . This study compare various program setting bilateral stimulation STN use BSC implantable Vercise™ DBS System treatment levodopa-responsive , moderate severe idiopathic PD .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Implanted bilaterally STN Vercise DBS system Parkinson 's disease least three month program optimize accord standard care . UPDRS subset III score ≥30 preoperative med state . DBS must improve PD symptom ≥30 % med state , measure UPDRS subset III score . Medical mental fitness comply program visit study related procedure . Able understand study requirement treatment procedure provide write informed consent studyspecific test procedure perform . Off symptom rigidity score ≥2 evaluate arm determine UPDRSIII . Have significant medical condition likely interfere study procedure likely confound evaluation study endpoint , include terminal illness survival &lt; 12 month . Resting and/or action tremor score ≥3 evaluate side determine UPDRSIII preoperative med condition .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Stimulation , implantable pulse generator , deep brain stimulation</keyword>
</DOC>